Trials / Unknown
UnknownNCT01355666
Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting
Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- Precision Fabrics Group, Inc. · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The primary purpose of this research study is to evaluate if DermaTherapy® bedding will significantly reduce pressure ulcer incidence by decreasing maceration, friction, and shearing among residents of Nursing Homes.
Detailed description
Additional objectives of this research study are: * To evaluate healing of pressure ulcers already present or pressure ulcers that develop during the study. * To evaluate the effectiveness of DermaTherapy® bedding and alternative diapers to reduce the potential for bacterial contamination associated with patients' bed linens, underpads, gowns and pajamas, and thereby help reduce the incidence of facility-acquired infections. Study nurses will assess the skin of the subjects once or twice a week for the presence of pressure ulcers and measure the size of the pressure ulcers if they are present. Study nurses will also obtain bacterial culture swabs of the bedding weekly for the first eight weeks of the study from five participants in each group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DermaTherapy® Linen and underpads. | DermaTherapy® Linen is a 100% synthetic silk-like fabric technology designed to provide a cleaner, drier and smoother surface between the skin and support systems for a healthy micro-climate. Subjects in the DermaTherapy® Linen Group are compared to subjects receiving usual care - bed linen made of cotton-blend fabrics. |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-05-01
- Completion
- 2011-06-01
- First posted
- 2011-05-18
- Last updated
- 2011-05-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01355666. Inclusion in this directory is not an endorsement.